Interested participants and investors for the conference call by dialing 860-2442 or 858-4600 An audio webcast will be accessible through. The Investor Relations section of of the website AspenBio – are key words for this news article : pharmaceutical Companies AspenBio Pharma Inc.
AspenBio senior management will discuss a conference call and audio webcast on Wednesday, August 2012.00 clock ET on recent activities and upcoming plans for clinical development and potential commercialization of AppyScore? (See also AspenBio Pharma.. Development of new and hopefully more effective supplements is ongoing.Funding for this study was supported by the Natural Sciences and Engineering Research Council of Canada provided.AspenBio Pharma to Shareholders with Business Update offer by a News Reporter Staff News Editor at Business Week AspenBio pharmaceutical Pharma: known, an in vitro diagnostics company, announced that it will begin hosting regular conference calls to provide its investors and the broader investment and medical communities with timely updates on the Company’s business and the expected milestones.U.S. And Japan: Osteologix patent protection for their patent protection for its new osteoporosis therapy of the three major pharmaceutical markets in the world.. Jn the world. – Receives Positive decisions, Patents Key Osteoporosis Drug patents in Japan Granting.
Osteologix, aware that the Japanese Patent Office was a decision of, a patent on Application Number 2006-504379 Decision to Grant: ‘The / / bone terms with water-soluble strontium salts thereof ‘. Patent claims include treatment of osteoporosis and related tissue disorders by NB S101 , the Company’s perform osteoporosis drug Contestant.